Table 2.
Opportunities for improvement (n = 30) | |||
---|---|---|---|
Total | To achieve targets similar to CHD QOFa | Predicted from nurse-led clinics in CHDb | |
Antiplatelet drugs | 15 | 12 | 3 |
Cholesterol <5.0 mmol/l (n = 29) | 16 | 7 | 6 |
Blood pressure <140/85 mmHg | 14 | 5 | 3 |
Non-smoking | 8 | - | 0 |
Moderate exercise | 28 | - | 2 |
Low-fat diet | 16 | - | 2 |
Total | |||
Per 30 patients | 97 | 24 | 16 |
Per patient | 3.2 | 0.8 | 0.5 |
Maximum targets for secondary prevention of coronary heart disease (CHD) in the Quality Outcomes Framework (QOF) of the UK general medical services contract: 90% on antiplatelet drugs, 70% achieving cholesterol and blood pressure targets.4
Based on outcomes achieved in a previous randomised controlled trial: 9% more on antiplatelet drugs, 21% more achieving cholesterol targets, 10% more achieving blood pressure targets, no change in smoking, 6% more exercising, and 8% more on a low-fat diet.28